Unlocking Colchicine's Untapped Potential: A Paradigm Shift in Hepatocellular Carcinoma Prevention

Area of Science:

• Hepatology
• Oncology
• Pharmacology

Background:

• Liver cancer, particularly hepatocellular carcinoma (HCC), causes high global mortality.
• Chronic hepatitis and fatty liver are key precursors, necessitating preventive measures.
• Colchicine, known for anti-inflammatory effects, is explored for liver cancer prevention.

Purpose of the Study:

• To investigate the association between colchicine use and liver cancer risk.
• To explore colchicine's potential role in preventing hepatocellular carcinoma.
• To analyze the impact of colchicine on liver cancer incidence.

Main Methods:

• Retrospective analysis of medical data from Taiwan's iHi Data Platform.
• Inclusion of 10,353 patients in both Colchicine and Non-Colchicine cohorts over two decades.
• Multivariable analysis to adjust for confounding variables like gender and diabetes mellitus.

Main Results:

• Colchicine users showed a 19% reduction in liver cancer risk (OR 0.81).
• Prolonged colchicine use correlated with better outcomes, suggesting a dose-response effect.
• Gender and comorbidities like diabetes mellitus were confirmed as influencing liver cancer risk.

Conclusions:

• Colchicine may offer a novel approach to liver cancer prevention beyond its anti-inflammatory uses.
• Findings suggest a potential role for colchicine in reducing hepatocellular carcinoma incidence.
• Further clinical trials are needed to validate colchicine's efficacy and impact on preventive strategies.